Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Kidney Injury II: Pathophysiology

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...

Acute Kidney Injury I: Introduction

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Neutrophil serine proteases degrade endothelial cortactin and promote extravasation.

The Journal of cell biology·2026

Same author

Analysis of Vascular Permeability by a Modified Miles Assay.

Bio-protocol·2025

Same author

Arpin deficiency increases actomyosin contractility and vascular permeability.

eLife·2024

Same author

Erk1/2 is not required for endothelial barrier establishment despite its requirement for cAMP-dependent Rac1 activation in heart endothelium.

Tissue barriers·2024

Same author

Potentiation of anti-angiogenic eNOS-siRNA transfection by ultrasound-mediated microbubble destruction in ex vivo rat aortic rings.

PloS one·2024

Same author

Cxcl1 monomer-dimer equilibrium controls neutrophil extravasation.

Journal of leukocyte biology·2023

Search research articles

Related Experiment Video

Updated: May 27, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Cyclooxygenase-2 and kidney failure.

Amelia Rios¹, Hilda Vargas-Robles, Ana Maria Gámez-Méndez

¹CINVESTAV Monterrey, Apodaca, N.L.México, Mexico. arios@cinvestav.mx

Prostaglandins & Other Lipid Mediators

|November 29, 2011

Summary

Cyclooxygenase-2 (COX-2) is crucial for kidney function and its expression increases during kidney failure. COX-2 inhibition may prevent kidney damage but carries risks like edema and cardiovascular complications, requiring cautious use.

More Related Videos

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Related Experiment Videos

Last Updated: May 27, 2026

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Modeling Hypoxia/Reoxygenation Injury in Proximal Tubular Epithelial Cells

Published on: November 21, 2025

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Identification of the Source of Secreted Proteins in the Kidney by Brefeldin A Injection

Published on: November 10, 2021

A Mouse 5/6th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

A Mouse 5/6^th Nephrectomy Model That Induces Experimental Uremic Cardiomyopathy

Published on: November 7, 2017

Area of Science:

Nephrology
Molecular Biology
Pharmacology

Background:

Cyclooxygenase (COX)-dependent prostaglandins are vital for normal kidney function, influencing inflammation, fluid balance, and blood pressure regulation.
COX-2 expression is modulated by the renin-angiotensin system and corticosteroids, highlighting its role in renal physiology.
Elevated COX-2 mRNA, protein, and enzyme activity, along with increased PGE2, are observed during kidney failure.

Purpose of the Study:

To review the role of COX-2 in kidney function and kidney failure.
To discuss the mechanisms regulating COX-2 expression in the kidney.
To evaluate the clinical implications and risks associated with COX-2 inhibition in kidney disease.

Main Methods:

Literature review of studies on COX-2, prostaglandins, and kidney function.
Analysis of molecular mechanisms regulating COX-2 expression in renal tissue.
Examination of clinical trial data regarding COX-2 inhibitor use in patients with kidney conditions.

Main Results:

COX-2 expression and activity are upregulated in kidney failure, linked to increased blood pressure and altered urinary parameters.
Intrarenal factors like angiotensin II, increased sodium delivery, and tubular inflammation contribute to elevated COX-2.
COX-2 inhibition shows potential in preventing kidney damage but can lead to side effects such as edema and hypertension.

Conclusions:

COX-2 plays a significant role in maintaining kidney function and is implicated in kidney failure.
Careful consideration of risks, including cardiovascular complications and drug interactions, is necessary when administering COX-2 inhibitors, particularly in patients with pre-existing cardiovascular disease.